Results 91 to 100 of about 1,042 (177)

New mechanism underlying IL-31-induced atopic dermatitis [PDF]

, 2018
LBK
Buddenkotte, Joerg, Buhl, Timo, Feld, Micha, Fischer, Michael, Ghetti, Andre, Meng, Jianghui, Miller, Paul, Moriyama, Masaki, Reeh, Peter W., Shan, Chunxu, Steinhoff, Martin, Szöllősi, Attila Gábor, Wang, Jiafu, Zhang, Jingming   +13 more
core   +1 more source

Dupilumab Reduces Pruritus in Twins With Sjögren–Larsson Syndrome

Pediatric Dermatology, EarlyView.
ABSTRACT Sjögren–Larsson Syndrome (SLS), now termed ALDH3A2‐syndromic epidermal differentiation disorder (sEDD), is a rare genetic disorder marked by thickened skin, spasticity, and intellectual disability. Intractable pruritus is a nearly universal and debilitating feature of SLS that remains poorly managed by current therapies. We describe 4‐year‐old
Kennedy Gallagher, Rame Yousif, Kathryn Hummel, Amy S. Paller   +3 more
wiley   +1 more source

Bullous Pemphigoid that Developed During Nemolizumab Treatment for Atopic Dermatitis: Two Case Reports

Acta Dermato-Venereologica
is missing (Short communication)
Michie Katsuta, Ryoichi Kamide, Yozo Ishiuji, Yoshimasa Nobeyama, Akihiko Asahina   +4 more
doaj   +1 more source

Recent advances in treatment of prurigo nodularis

Dermatologica Sinica
Prurigo nodularis is a chronic skin condition which has significant negative impacts on the psychosocial function and quality of life of affected patients.
Chieh-Hsun Chen, Stephen Chu-Sung Hu
doaj   +1 more source

Conventional and biological therapies in atopic dermatitis – a literature review [PDF]

, 2023
Introduction: Atopic dermatitis is a chronic, relapsing disease with a multifactoral etiology. The basic disorder of the atopic dermatitis is the disruption of the epidermal barrier. The family history of atopy is a high risk factor of the development of
Gonet, Malwina, Kania, Agata, Lazar, Michał, Maj, Patrycja, Maternia, Jakub, Miszczyk, Karolina, Mozer, Piotr, Sergiel, Natalia, Serwik-Trandasir, Aleksandra, Włodarczyk-Cybulska, Karolina   +9 more
core   +1 more source

Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2024

Allergology International
This is an abridged edition of English version of the Clinical Practice Guidelines for the Management of Atopic Dermatitis 2024. Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion.
Hidehisa Saeki, Yukihiro Ohya, Hirokazu Arakawa, Susumu Ichiyama, Toshio Katsunuma, Norito Katoh, Akio Tanaka, Hideaki Tanizaki, Yuichiro Tsunemi, Takeshi Nakahara, Mizuho Nagao, Masami Narita, Michihiro Hide, Takao Fujisawa, Masaki Futamura, Koji Masuda, Tomoyo Matsubara, Hiroyuki Murota, Kiwako Yamamoto-Hanada, Junichi Furuta   +19 more
doaj   +1 more source

The role of CLA+T lymphocytes in the development of Atopic Dermatitis [PDF]

, 2023
[eng] Atopic dermatitis is the most common chronic immune-mediated inflammatory skin disease affecting up to 20% of children and 10% of adults. The complex pathophysiology of the disease comprises genetic susceptibility, epidermal barrier dysfunction ...
Sans de San Nicolàs, Lídia
core   +3 more sources

Biologic and Small Molecule Therapy in Atopic Dermatitis

Biomedicines
Atopic dermatitis is a chronic inflammatory dermatosis characterized by pruritic, scaly, erythematous lesions. Its incidence varies but is estimated to be approximately 20% in children and between 7 and 14% in adults, with variation amongst countries. It
Mahek Shergill, Barinder Bajwa, Orhan Yilmaz, Karishma Tailor, Naila Bouadi, Ilya Mukovozov   +5 more
doaj   +1 more source

Clinical perspectives on prurigo nodularis: diagnostic challenges and novel treatment options [PDF]

Prurigo nodularis (PN) is a chronic skin inflammatory condition characterized by severe, persistent itching and excoriated nodules induced by scratching.
Andrea CHIRICOZZI, Anna CAMPANATI, Cataldo PATRUNO, Caterina FOTI, Claudia DE CUPIS, Giampiero GIROLOMONI, Luca STINGENI, Maria Concetta FARGNOLI, Piergiacomo CALZAVARA-PINTON, Silvia Mariel FERRUCCI, Simmi WIGGINS   +10 more
core   +1 more source

Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis [PDF]

Background Prurigo nodularis (PN) is a debilitating skin condition. When inadequate disease control is achieved or other systemic therapies are contraindicated, Janus kinase inhibitors (JAKis) may be considered, although real-world evidence remains ...
Alessandra Narcisi, Andrea Bombelli, Angelo V Marzano, Anna Balato, Benedetta Galli, Carlotta Gurioli, Cataldo Patruno, Caterina Foti, Elena Pezzolo, Elia Esposto, Emanuele Cozzani, Enzo Errichetti, Eustachio Nettis, Fabrizio Guarneri, Francesca Barei, Francesca Caroppo, Francesca di Vico, Franco Rongioletti, Giampiero Girolomoni, Gianluca Avallone, Gianluca Tavoletti, Ilaria Trave, Katharina Hansel, Ketty Peris, Laura Bonzano, Laura Calabrese, Laura Del Regno, Laura Lazzeri, Luca Mastorino, Luca Stingeni, Luca Valtellini, Luigi Gargiulo, Maddalena Napolitano, Maria C Fargnoli, Maria Esposito, Mariateresa Rossi, Martina Maurelli, Michela Ortoncelli, Niccolò Gori, Paola Savoia, Paolo Calzari, Roberta Giuffrida, Serena Lembo, Silvia M Ferrucci, Simone Ribero, Stefano Caccavale, Sveva Lenti   +46 more
core   +1 more source